Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Phase 1, Double-blind, Placebo-controlled Crossover Study of SAGE-718 Using a Ketamine Challenge, to Evaluate the Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Subjects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03771586

Organisation Name: Sage Therapeutics

Overal Status: Completed

Start Date: September 24, 2018

Last Update: February 11, 2019

Lead Sponsor: Sage Therapeutics

Brief Summary: This study is a phase 1, double-blind, placebo-controlled crossover study of single, oral dose of SAGE-718 using a ketamine challenge, to evaluate the electrophysiology, safety, tolerability, and pharmacokinetics in healthy subjects

Conditions:
  • Healthy Volunteer


Total execution time in seconds: 0.1993579864502